Pharma Mar SA (PHM) Stock Statistics & Valuation Metrics

Pharma Mar SA has a market cap or net worth of $1.40B. The enterprise value is €1.32B.

Pharma Mar SA has 18,222,227 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharma Mar SA’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 5.09%.

The current PE Ratio of Pharma Mar SA is 32.5. Pharma Mar SA’s PEG ratio is 0.02.

In the last 12 months, Pharma Mar SA had revenue of 174.85M and earned 26.13M in profits. Earnings per share was 1.48.

In the last 12 months, operating cash flow was 8.80M and capital expenditures -7.52M, giving a free cash flow of 1.28M billion.

Pharma Mar SA pays an annual dividend of €0.8, resulting in a dividend yield of 1.01%

Pharma Mar SA upcoming earnings date is Nov 11, 2025, TBA (Confirmed).

Pharma Mar SA as a current ratio of 3.03, with Debt / Equity ratio of 25.50%

In the past 12 months, Pharma Mar SA has paid -14.14M in taxes.

Pharma Mar SA EV to EBITDA ratio is 65.37, with an EV/FCF ratio of -146.31.

Pharma Mar SA has $128.08M in cash and marketable securities with $51.40M in debt, giving a net cash position of -$76.68M billion.

Gross margin is 94.98%, with operating margin of 3.70%, and net profit margin of 14.94%.

The average price target for Pharma Mar SA is $110.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy